Results 141 to 150 of about 2,340 (177)
Some of the next articles are maybe not open access.
[Risks of prolonged tocolysis].
Revue francaise de gynecologie et d'obstetrique, 1995Premature delivery menace is still a major issue in obstetrics. It concerns 4 to 5% of the pregnancies. Being responsible of an important fetal morbidity, it implies the use of a rapid and efficient treatment. This treatment uses progestins, prostaglandins inhibitors and beta-mimetics. The more efficient these medicines are, the more dangerous is their
P, Mironneau, J M, Thoulon
openaire +1 more source
Journal de gynecologie, obstetrique et biologie de la reproduction, 2016
Tocolytic agents have limited efficacy, delaying preterm delivery by 48 hours to 7 days, without any neonatal benefit. Cyclo-oxygenase inhibitors and calcium canal inhibitors seem to be the most efficient. Betamimetics are tocolytic agents with the highest incidence of severe maternal side effects.
openaire +1 more source
Tocolytic agents have limited efficacy, delaying preterm delivery by 48 hours to 7 days, without any neonatal benefit. Cyclo-oxygenase inhibitors and calcium canal inhibitors seem to be the most efficient. Betamimetics are tocolytic agents with the highest incidence of severe maternal side effects.
openaire +1 more source
Nifedipine maintenance tocolysis and perinatal outcome: an individual participant data meta‐analysis
BJOG: an International Journal of Obstetrics and Gynaecology, 2016Ewoud Schuit +2 more
exaly
Pulsatile vs. continuous parenteral tocolysis: comparison of side effects
European Journal of Obstetrics, Gynecology and Reproductive Biology, 1999Walther Kuhn, R Osmers
exaly
The efficacy of oral terbutaline after intravenous tocolysis
American Journal of Obstetrics and Gynecology, 1993Michael L Socol
exaly